PsychoGenics Tech Stack

Preclinical CRO for CNS drug efficacy validation using disease models and behavioral assays

Research Services Paramus, New Jersey 51–200 employees Privately Held

PsychoGenics is a preclinical contract research organization focused on CNS and orphan disorder drug discovery. The tech stack reveals a data-analytics pivot: Python, NumPy, Pandas, Jupyter, and GraphPad Prism sit alongside core lab instrumentation, while active projects show ML/DL model deployment, EEG time-series analytics, and ETL pipelines for behavioral datasets. This signals a shift from manual data interpretation toward automated quantification of treatment response—directly addressing their stated pain point of reducing clinical attrition by identifying efficacy signals earlier in preclinical studies.

Tech Stack 18 technologies

Core StackPython NumPy Pandas GitHub C++ C# Java AWS Docker Microsoft Office Excel Word Jupyter Transformers Git Azure GCP GraphPad Prism

What PsychoGenics Is Building

◆Challenges

Reduce attrition rate in clinical development
Accelerating learning across trials
Quantifying treatment response
Improve automation of data processing

▲Active Projects

Efficacy studies of novel test articles and genetic manipulations for cns diseases
Experiments analyzing eeg changes induced by pharmaceutical agents and genetic models for seizures, erps, and sleep
Overseeing studies including surgeries, dosing, and eeg recordings
Breeding and maintenance of transgenic mouse and rat models
Ml/dl models for eeg and behavioral datasets
Time-series analytics and feature engineering
Dashboards and visualizations for translational insights
Ml/dl model deployment into production workflows
Etl/data pipelines for eeg/behavioral modalities
Api and services for internal analytics and trial-facing platforms

Hiring Activity

Decelerating10 roles · 3 in 30d

Department

Research

Data

Engineering

Ops

Seniority

Junior

Mid

Senior

Director

Company intelligence

Find more companies like PsychoGenics by tech stack, pain points and active projects

Get started free

About PsychoGenics

PsychoGenics operates a preclinical CRO serving biopharmaceutical companies developing CNS and orphan disorder treatments. The company maintains a portfolio of validated transgenic mouse and rat disease models (Alzheimer's, Huntington's, Parkinson's, autism spectrum disorders, psychosis, schizophrenia, spinal muscular atrophy, and pain models) and delivers behavioral testing, electrophysiology, EEG, quantitative histology, molecular biology, and microdialysis services. Core clients are biopharma firms at all development stages seeking to de-risk candidate molecules before clinical trials. The 51–200 employee organization is headquartered in Paramus, New Jersey.

HeadquartersParamus, New Jersey

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What is PsychoGenics' preclinical expertise?

PsychoGenics specializes in CNS and orphan disorder drug efficacy validation using validated transgenic disease models, behavioral assays, electrophysiology, EEG, histology, molecular biology, and microdialysis. The company maintains models for Alzheimer's, Huntington's, Parkinson's, autism spectrum disorders, psychosis, schizophrenia, spinal muscular atrophy, and pain conditions.

What tech stack does PsychoGenics use?

PsychoGenics uses Python, NumPy, Pandas, Jupyter, and GraphPad Prism for data analysis, alongside AWS, Azure, and GCP cloud platforms. The company is actively deploying ML/DL models for EEG and behavioral datasets and building ETL pipelines and analytics dashboards for trial data.